Action 17
Engage in early and regular consultations with the PAWG on PIP/PSPs, as well as recommended dosing and ratios for FDC development.
Committed by:
Pharmaceutical companies
Sub-Actions & Milestones
Sub-action 17.2

Recommend dosing and ratios for FDC development.

-

-

-

Milestone 17.2.1

-

-

-

-

Document (s)

-

-

-

-

Sub-action 17.1

Engage in early and regular consultations with the PAWG on PIP/PSPs

Pharmaceutical Companies

-

-

Milestone 17.1.1

-

-

-

-

Document (s)

-

-

-

-

Updates

Notes

Responsible